Search for: "Pharmaceutical Associates, Inc." Results 401 - 420 of 1,889
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2017, 3:47 am by Law Offices of Jeffrey S. Glassman
Additionally, the drug has been associated with various other serious psychological issues. [read post]
12 May 2009, 2:44 am
The drug was developed by OSI Pharmaceuticals Inc. and is sold by Genentech. [read post]
19 Apr 2021, 9:37 am by Deb Givens
A three-judge 4th Circuit panel found that claims brought by the City of Baltimore and the Government Employees Health Association, a healthcare provider for federal workers, shouldn’t have been found to be time-barred by U.S. [read post]
11 Jan 2018, 12:30 pm by Tom Lamb
Boehringer Ingelheim Pharmaceuticals, Inc. is the drug company responsible for OFEV in the US. [read post]
2 Oct 2013, 6:00 am by John Ottaviani
·               Mnemosyne Pharmaceuticals Inc., of Providence, received a $5,166,000 early stage investment from existing investors Atlas Venture Advisors Inc. and Clol Biotechnology Industries, Ltd. [read post]
2 Oct 2013, 6:00 am by John Ottaviani
·               Mnemosyne Pharmaceuticals Inc., of Providence, received a $5,166,000 early stage investment from existing investors Atlas Venture Advisors Inc. and Clol Biotechnology Industries, Ltd. [read post]
4 Dec 2018, 10:35 am by Renae Lloyd
According to FINRA BrokerCheck, VonLutzow was registered with Oberwies Securities Inc. in Sarasota, FL from May 2003 until December 2016. [read post]
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
 is an Associate Attorney in the MVS Biotechnology & Chemical Practice Group. [read post]
6 Aug 2012, 1:24 pm by Brenda Fulmer
This first lawsuit was filed in the San Francisco County Superior Court asserting that AstraZeneca Pharmaceuticals, Inc. and Takeda Pharmaceuticals USA, Inc. failed to conduct adequate and sufficient post-marketing surveillance of adverse events caused by ingestion of Nexium and Prevacid after they began marketing the drug. [read post]
Zydus Pharmaceuticals (USA) Inc., a Delaware district court recently found two patents directed to methods of mobilizing progenitor/stem cells from bone marrow to the peripheral blood stream for use in stem cell transplantation valid under 35 U.S.C. [read post]